Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium

被引:141
作者
Troutman, MD [1 ]
Thakker, DR [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Div Drug Delivery & Disposit, Chapel Hill, NC 27599 USA
关键词
P-glycoprotein; intestinal absorption; absorptive quotient; P-gp expression; passive permeability;
D O I
10.1023/A:1025001131513
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this work was to elucidate the asymmetric effect of P-gp on modulation of absorptive and secretory transport of compounds across polarized epithelium, to develop experimental parameters to quantify P-gp-mediated modulation of absorptive and secretory transport, and to elucidate how P-gp-mediated modulation of transport is affected by passive diffusion properties, interaction of the substrate with P-gp, and P-gp expression. Methods. The permeability of a set of P-gp substrates was determined in absorptive and secretory directions in Madine-Darby Canine kidney (MDCK), Caco-2, and MDR-MDCK monolayers. The transport was also determined in the presence of GW918, a non-competitive P-gp inhibitor, to quantify the permeability without the influence of P-gp. From these two experimental permeability values in each direction, two new parameters, absorptive quotient (AQ) and the secretory quotient (SQ), were defined to express the functional activity of P-gp during absorptive and secretory transport, respectively. Western blot analysis was used to quantify P-gp expression in these monolayers and in normal human intestinal. Results. P-gp expression in Caco-2 and MDR-MDCK monolayers was comparable to that in normal intestine, and much less in MDCK cells. For all models, the substrates encompassed a wide range of apparent permeability due to passive diffusion (PPD). The parameters AQ and SQ, calculated for all compounds, assessed the attenuation in absorptive and enhancement of secretory transport, respectively, normalized to the permeability due to passive diffusion. Analysis of these parameters showed that 1) P-gp affected absorptive and secretory transport differentially and 2) compounds could be stratified into distinct groups with respect to the modulation of their absorptive and secretory transport by P-gp. Compounds could be identified whose absorptive transport was either strongly affected or poorly affected by changes in P-gp expression. For certain compounds, AQ values showed parabolic relationship with respect to passive diffusivity, and for others AQ was unaffected by changes in passive diffusivity. Conclusions. The relationship between attenuation of absorptive transport and enhancement of secretory transport of compounds by P-gp is asymmetric, and different for different sets of compounds. The relationship between attenuation of absorption by P-gp and passive diffusivity of compounds, their interaction potential with P-gp, and levels of P-gp expression is complex; however, compounds can be classified into sets based on these relationships. A classification system that describes the functional activity of P-gp with respect to modulation of absorptive and secretory transport was developed from these results.
引用
收藏
页码:1210 / 1224
页数:15
相关论文
共 58 条
[11]   Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans [J].
Gramatte, T ;
Oertel, R ;
Terhaag, B ;
Kirch, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (05) :541-549
[12]   Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil [J].
Gramatté, T ;
Oertel, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) :239-245
[13]   The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin [J].
Greiner, B ;
Eichelbaum, M ;
Fritz, P ;
Kreichgauer, HP ;
Von Richter, O ;
Zundler, J ;
Kroemer, HK .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :147-153
[14]   Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery [J].
Hebert, MF .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) :201-214
[15]   BIOPHYSICAL MODEL OF PASSIVE AND POLARIZED ACTIVE-TRANSPORT PROCESSES IN CACO-5 CELLS - APPROACHES TO UNCOUPLING APICAL AND BASOLATERAL MEMBRANE EVENTS IN THE INTACT CELL [J].
HO, NFH ;
BURTON, PS ;
CONRADI, RA ;
BARSUHN, CL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (01) :21-27
[16]  
HORIO M, 1989, J BIOL CHEM, V264, P14880
[17]   DRUG ABSORPTION LIMITED BY P-GLYCOPROTEIN-MEDIATED SECRETORY DRUG TRANSPORT IN HUMAN INTESTINAL EPITHELIAL CACO-2 CELL-LAYERS [J].
HUNTER, J ;
HIRST, BH ;
SIMMONS, NL .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :743-749
[18]  
HYAFIL F, 1993, CANCER RES, V53, P4595
[19]   Simulated intestinal fluid as transport medium in the Caco-2 cell culture model [J].
Ingels, F ;
Deferme, S ;
Destexhe, E ;
Oth, M ;
Van den Mooter, G ;
Augustijns, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) :183-192
[20]   Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells [J].
Ito, S ;
Woodland, C ;
Sarkadi, B ;
Hockmann, G ;
Walker, SE ;
Koren, G .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (01) :F84-F96